Ceiling Test Impairment Under Full Cost Accounting

Introduction

The ceiling test is the impairment mechanism for E&P companies that use the full cost accounting method. It is a quarterly, formulaic comparison between the net book value of the company's oil and gas cost pool and a calculated "ceiling" that represents the economic value of the underlying reserves. When the net book value exceeds the ceiling, the company must record a non-cash impairment charge that permanently reduces the carrying value of its assets. These write-downs can be enormous during commodity downturns: Ovintiv recorded a $1.34 billion ceiling test impairment in 2020, and Ring Energy recorded $35.9 million in Q4 2025 due to declining trailing commodity prices.

For energy bankers, the ceiling test matters for three reasons. First, ceiling test write-downs can distort reported earnings and must be excluded from cash-flow-based metrics like EBITDAX. Second, the ceiling test calculation uses a specific commodity price input (the trailing 12-month average) that may differ significantly from the current spot price or strip pricing, creating timing disconnects between market conditions and impairment recognition. Third, understanding the ceiling test is essential for analyzing FC companies in M&A and for comparing impairment risk across FC and successful efforts companies.

Ceiling Test

The quarterly impairment test required for E&P companies using the full cost accounting method, prescribed by SEC Regulation S-X Rule 4-10. The test compares the net book value of the company's oil and gas cost pool to a calculated ceiling amount (based primarily on the PV-10 of proved reserves at the trailing 12-month average commodity price). If the book value exceeds the ceiling, the company must record a non-cash, irreversible write-down equal to the excess. The ceiling test is the primary mechanism by which commodity price declines translate into balance sheet adjustments for FC companies.

The test requires the following quarterly comparison:

If: Net Book Value of Cost Pool > Ceiling Amount, then: Record Impairment = Net Book Value minus Ceiling Amount

The ceiling amount is calculated as:

The resulting ceiling amount represents the maximum carrying value of the cost pool. Any excess must be written down immediately.

Trailing 12-Month Average Price

The commodity price used in the ceiling test PV-10 calculation is not the current spot price or the futures strip. It is the unweighted arithmetic average of the first-day-of-the-month price for each of the 12 months preceding the reporting date. For example, the Q4 2025 ceiling test uses the average of the January 2025 through December 2025 first-day-of-month prices. This trailing average smooths short-term price volatility but also creates a lag: when prices drop suddenly, the 12-month average declines gradually over several quarters, potentially delaying impairment recognition (and conversely, when prices recover, the average takes time to catch up).

The ceiling test is driven almost entirely by commodity prices. The net book value of the cost pool changes slowly (through capital spending and DD&A), but the ceiling amount is highly sensitive to the trailing 12-month price input. When commodity prices decline, PV-10 falls, the ceiling drops, and the gap between the cost pool's book value and the ceiling narrows or inverts, triggering an impairment.

Commodity price declines are the primary trigger. Every sustained commodity downturn produces widespread ceiling test impairments among FC companies. The 2015-2016 oil price collapse, the 2020 COVID crash, and the late-2025 softening in prices all triggered write-downs at FC companies ranging from tens of millions to billions of dollars.

Negative reserve revisions also reduce the ceiling because PV-10 is calculated based on proved reserves. If a company reduces its proved reserve estimates (due to underperforming wells, reclassification of PUD reserves, or geological reassessments), PV-10 declines even if commodity prices are unchanged.

High historical cost basis makes some companies more vulnerable than others. An FC company that accumulated a large cost pool through expensive acquisitions or extensive unsuccessful exploration has a higher net book value that is more likely to exceed the ceiling during a downturn. This is a structural weakness of the full cost method: past overspending (on acquisitions or failed exploration) can remain hidden in the cost pool during good times but surfaces as an impairment during bad times.

The ceiling test is fundamentally different from the impairment framework for successful efforts companies under ASC 360, and understanding these differences is important for cross-method comparisons and interview preparation.

The practical consequence is that FC companies record impairments more frequently and more predictably than SE companies during commodity downturns. The quarterly cadence, the formulaic trailing price input, and the aggregate pool-level test make the ceiling test highly mechanical. SE impairments, by contrast, require management judgment about triggering events, are tested at the individual property level (where some properties may pass even if the portfolio is under stress), and use undiscounted cash flows as the first threshold (which are always higher than discounted values, providing more headroom).

In financial analysis, always exclude ceiling test impairments from cash-flow-based metrics. EBITDAX, operating cash flow, and free cash flow are unaffected by non-cash write-downs. However, impairments do affect reported net income, shareholders' equity, and return-on-equity metrics. When building comparable company analyses, bankers must normalize for ceiling test charges to avoid distorting profitability comparisons between FC and SE companies.

In M&A, the target's impairment history provides information about its historical cost basis and commodity price resilience. A company that has recorded multiple ceiling test write-downs has effectively "cleansed" its cost pool of excess historical costs, resulting in a lower going-forward cost base. Paradoxically, a company that has been impaired may have a more attractive cost structure post-impairment than an otherwise identical company that has never been impaired (because its DD&A rate is lower).

In reserve-based lending, lenders monitor the ceiling test closely because a large impairment signals that the collateral value (proved reserves) may be insufficient to support the borrowing base. A ceiling test write-down often coincides with or precedes a borrowing base reduction at the next semiannual redetermination, creating a potential liquidity squeeze for leveraged FC companies during commodity downturns.